The breakthrough research holds promise for developing diagnostic tests for the prediction of cancer progression and therapy.
Building upon his laboratory’s many discoveries centered around ILC3s, Dr. Gregory Sonnenberg has published another breakthrough in Nature (September 7, 2022).
This five-year, $1.25 million grant will enable Dr. Iliev to continue his innovative research into the relationship between certain types of fungi and specific cancers.
This award recognizes exceptional researchers whose scientific excellence and pioneering work have significantly advanced scientific development for the benefit of humanity.
The interdepartmental and interdisciplinary celebration of quality and patient safety initiatives included 27 projects from 13 departments across WCM, Lower Manhattan Hospital, NYP/Queens, and NYP/Brooklyn Methodist.
The WDOM congratulates four of its physician-scientists who have recently been inducted into top-tier medical societies: Dr. Longman and Dr. Schwartz (ASCI); Dr. Fins and Dr. Rafii (AAP).
Dr. Rachel Niec and Dr. Melanie H. Smith have each received an Emerging-Generation Award (2022) from the American Society of Clinical Investigation (ASCI).
Using a mouse model, researchers have revealed molecular signals that connect a specific group of fungi in the gut to cells throughout the host’s body, including immune cells and neurons.
The research suggests that countering the activity of inflammatory ILC3s could lead to a therapeutic approach for multiple sclerosis and other brain disorders.
Lectures were provided by WDOM faculty and keynote speaker, Dr. Drew Weissman, who played a major role in critical discoveries that allowed for the mRNA platform to be used in developing vaccines against SARS-CoV.
